THE VALUED VOICE

Vol. 60, Issue 37
Click here to view past issues
Friday, September 16, 2016

   

WHA Convenes Leaders in Health Care from Around the State to Develop Action Plan to Battle Ongoing Opioid Abuse

WHA President/CEO Eric Borgerding set the tone for the September 9 meeting held at WHA of the Wisconsin Prescription Drug Abuse Coalition when he stated, “This is a critically important, yet complex issue. The leaders in this room today possess the knowledge and resources to make significant change.” 

Borgerding commended the work of the Coalition in identifying key issues and then crafting plans and strategies, though recognized the challenges ahead.

Wisconsin Attorney General Brad Schimel continued the praise and acknowledgement of the Coalition saying, “This is phenomenal work. I am the envy of all the attorneys general in the country. We are frequently asked to give presentations at national meetings to teach others how we achieved this level of collaboration with health care providers. Wisconsin is collaborative, cooperative and comprehensive in its approach to stopping the opioid epidemic here.” 

Wisconsin State Rep. John Nygren (R-Marinette), the leader of Wisconsin’s Heroin, Opiate, Prevention and Education (HOPE) agenda, then called the work of the group “groundbreaking” with a diverse group of health care providers focused on addressing the problem. 

Stakeholders from around the state, which included representation from hospitals and health care systems, physicians, nurses, dentistry and pharmacy, all provided updates on how their constituents and members are supporting the Coalition’s agenda in reducing the overuse and abuse of prescription drugs. 

Multiple strategies were shared, including educating providers on the new prescription drug monitoring program (PDMP) requirements set to go into effect January 2017, as well as the recently-adopted Medical Examining Board responsible prescribing guidelines. It was shared that other health care professionals with prescription authority are beginning their work on responsible prescribing guidelines. The Wisconsin Board of Nursing has begun the process, and the dental providers are expected to address this process soon.

There was discussion regarding specialty-specific prescribing guidelines as well as setting-specific guidelines. Setting-specific guidelines might address how opioids are utilized in an inpatient encounter and how providers might best inform and treat patients as to the management of their pain once they are discharged. Since patients are admitted into a hospital under a multitude of different medical specialties, a more general setting-specific guideline approach might best address the challenges identified by the Coalition in this area.

For more information contact Steven Rush, WHA vice president, workforce and clinical practice, at srush@wha.org or 608-274-1820

This story originally appeared in the September 16, 2016 edition of WHA Newsletter

WHA Logo
Friday, September 16, 2016

WHA Convenes Leaders in Health Care from Around the State to Develop Action Plan to Battle Ongoing Opioid Abuse

WHA President/CEO Eric Borgerding set the tone for the September 9 meeting held at WHA of the Wisconsin Prescription Drug Abuse Coalition when he stated, “This is a critically important, yet complex issue. The leaders in this room today possess the knowledge and resources to make significant change.” 

Borgerding commended the work of the Coalition in identifying key issues and then crafting plans and strategies, though recognized the challenges ahead.

Wisconsin Attorney General Brad Schimel continued the praise and acknowledgement of the Coalition saying, “This is phenomenal work. I am the envy of all the attorneys general in the country. We are frequently asked to give presentations at national meetings to teach others how we achieved this level of collaboration with health care providers. Wisconsin is collaborative, cooperative and comprehensive in its approach to stopping the opioid epidemic here.” 

Wisconsin State Rep. John Nygren (R-Marinette), the leader of Wisconsin’s Heroin, Opiate, Prevention and Education (HOPE) agenda, then called the work of the group “groundbreaking” with a diverse group of health care providers focused on addressing the problem. 

Stakeholders from around the state, which included representation from hospitals and health care systems, physicians, nurses, dentistry and pharmacy, all provided updates on how their constituents and members are supporting the Coalition’s agenda in reducing the overuse and abuse of prescription drugs. 

Multiple strategies were shared, including educating providers on the new prescription drug monitoring program (PDMP) requirements set to go into effect January 2017, as well as the recently-adopted Medical Examining Board responsible prescribing guidelines. It was shared that other health care professionals with prescription authority are beginning their work on responsible prescribing guidelines. The Wisconsin Board of Nursing has begun the process, and the dental providers are expected to address this process soon.

There was discussion regarding specialty-specific prescribing guidelines as well as setting-specific guidelines. Setting-specific guidelines might address how opioids are utilized in an inpatient encounter and how providers might best inform and treat patients as to the management of their pain once they are discharged. Since patients are admitted into a hospital under a multitude of different medical specialties, a more general setting-specific guideline approach might best address the challenges identified by the Coalition in this area.

For more information contact Steven Rush, WHA vice president, workforce and clinical practice, at srush@wha.org or 608-274-1820

This story originally appeared in the September 16, 2016 edition of WHA Newsletter

Other Articles in this Issue